PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)
Evidence-based recommendations on PredictSURE IBD and IBDX for guiding treatment of Crohn’s disease
Search results
11 results for ibd
-
-
Colonoscopic surveillance in adults with Ulcerative colitis, Crohn's disease or adenomas - Is this happening?
and over with ulcerative colitis or Crohn's disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to...
-
The committee recommends more research on: the accuracy of PredictSURE IBD and IBDX tests in identifying people at high or low risk of following a severe course of Crohn's disease how PredictSURE IBD and IBDX tests, when used alongside clinical features, affect clinical decisions about whether step-up or top-down treatment is offered the clinical outcomes and costs resulting from a top-down treatment strategy compared with a step-up treatment strategy how PredictSURE IBD and IBDX tests affect clinical outcomes once someone has been assigned to top-down or step-up treatment, considering the different pathways that children and adults may follow.
PredictSURE IBD and IBDX tests in identifying people at high or low risk of following a severe course of Crohn's disease how PredictSURE...
-
Manchester Royal Infirmary Virtual Biologics Clinic
gastroenterology and dermatology, including at an event for the National IBD audit. Implementing up-to-date high-quality research...
-
Bioprosthetic plug insertion for anal fistula (IPG662)
Evidence-based recommendations on bioprosthetic plug insertion for anal fistula in adults. This involves putting a plug into the fistula and stitching it in
-
Colorectal cancer (NG151)
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and secondary tumours (metastatic disease).
-
eXroid for internal haemorrhoids (MIB201)
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
-
Immunoscore for predicting risk of colon cancer relapse (MIB269)
NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse
-
The Insides System for managing intestinal failure (MIB286)
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure
-
Prostate cancer: diagnosis and management (NG131)
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.
-
Our endorsement programme has now closed
faecal calprotectin in primary care as a decision diagnostic for inflammatory bowel disease and irritable bowel syndrome A consensus...